Author: Hongyi Chen; Zhicheng Zhang; Li Wang; Zhihua Huang; Fanghua Gong; Xiaodong Li; Yahong Chen; Jinzi J. WU
Title: First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients Document date: 2020_3_24
ID: b3y9zxjr_15
Snippet: Efficacy endpoints include (1) time to discharge; (2) rate of two consecutive RT-PCR negative tests of SARS-CoV-2 nucleotide acid (respiratory track sampling and sampling interval at least one day apart); (3) lung imaging showing obvious absorption and recovery of acute exudative lesion ; (4) significantly improved respiratory symptoms; (5) normal body temperature for at least 3 days......
Document: Efficacy endpoints include (1) time to discharge; (2) rate of two consecutive RT-PCR negative tests of SARS-CoV-2 nucleotide acid (respiratory track sampling and sampling interval at least one day apart); (3) lung imaging showing obvious absorption and recovery of acute exudative lesion ; (4) significantly improved respiratory symptoms; (5) normal body temperature for at least 3 days.
Search related documents:
Co phrase search for related documents- acute exudative lesion and exudative lesion: 1, 2
- acute exudative lesion and nucleotide acid: 1, 2
- acute exudative lesion and obvious absorption: 1, 2
- acute exudative lesion and recovery obvious absorption: 1, 2
- acute exudative lesion and respiratory track sampling: 1, 2
- acute exudative lesion and SARS nucleotide acid: 1, 2
- acute exudative lesion and track sampling: 1, 2
- acute exudative lesion recovery obvious absorption and body temperature: 1, 2
- acute exudative lesion recovery obvious absorption and exudative lesion: 1, 2
- acute exudative lesion recovery obvious absorption and nucleotide acid: 1, 2
- acute exudative lesion recovery obvious absorption and obvious absorption: 1, 2
- acute exudative lesion recovery obvious absorption and recovery obvious absorption: 1, 2
- acute exudative lesion recovery obvious absorption and respiratory track sampling: 1, 2
- acute exudative lesion recovery obvious absorption and SARS nucleotide acid: 1, 2
- acute exudative lesion recovery obvious absorption and track sampling: 1, 2
- body temperature and exudative lesion: 1, 2
- body temperature and nucleotide acid: 1, 2
- body temperature and obvious absorption: 1, 2, 3
- body temperature and recovery obvious absorption: 1, 2
Co phrase search for related documents, hyperlinks ordered by date